Pharmaceutical Business News Set Back for Pancreatic Cancer: CARRIE study did not meet primary or secondary endpoints By Staff Reports 2 years ago Merrimack Pharmaceuticals, Inc., a clinical-stage oncology company focused on biomarker-defined cancers, today announced top-line results
Pharmaceutical Business News Merck’s Keytruda helps lung cancer patients live longer in trial By Staff Reports 2 years ago Merck & Co’s blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in
Biotechnology cancer Cancer Discovery Uncategorized Identifying a New Therapeutic Target for the Most Common Type of Lung Cancer By Staff Reports 2 years ago Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the
cancer Research suggests possible new treatment for EGFR-positive lung cancer By Staff Reports 3 years ago Findings from a phase III clinical trial point to a potential new treatment for patients
cancer Cancer Discovery Researchers inhibit tumor growth in new subtype of lung cancer By Staff Reports 4 years ago Lung cancer is the most common cause of cancer deaths, accounting for about a third